quintiles.com - information about domain
- Server Status: available
- Server IP: 174.143.17.180
- Server Response Time: 192ms
Site title
Pharmaceutical Clinical Research Organization CRO, CSO & Consulting - Quintiles
Keywords
Pharmaceutical Contract Research Organization, CRO, CSO, Consulting, Medical Device, Biotechnology, clinical studies, clinical research organization
Description
Quintiles clinical research organization (CRO), CSO, & Consulting services helps pharmaceutical, biotechnology and medical device companies develop and market innovative therapies.
Alexa information
Alexa rank: 151,842
Rank Trend
Bounce Trend
DNS Information
| Host: |
Class: |
Type: |
IP: |
TTL: |
Target: |
Other: |
| quintiles.com |
IN |
A |
174.143.17.180 |
9460 |
|
|
Server Location
Site source
Show / hide source
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<meta http-equiv="Content-Language" content="en" />
<title>
Pharmaceutical Clinical Research Organization CRO, CSO & Consulting - Quintiles
</title>
<link rel="shortcut icon" href="/elements/img/favicon.ico" />
<meta name="robots" content="INDEX, FOLLOW" />
<meta name="keywords" content="Pharmaceutical Contract Research Organization, CRO, CSO, Consulting, Medical Device, Biotechnology, clinical studies, clinical research organization" />
<meta name="description" content="Quintiles clinical research organization (CRO), CSO, & Consulting services helps pharmaceutical, biotechnology and medical device companies develop and market innovative therapies." />
<meta name="google-site-verification" content="O9zKdPO5t7OAlf661HQ5Up00EtmG6ZHA6p1Miw2IH8s" />
<link rel="stylesheet" media="all" href="/elements/css/base.css?cache=4" />
<link rel="stylesheet" media="all" href="/elements/css/styles.css?cache=4" />
<link rel="stylesheet" media="all" href="/elements/css/nav.css?cache=4" />
<link rel="stylesheet" type="text/css" href="/elements/css/home.css?cache=4" />
<link rel="stylesheet" type="text/css" href="/elements/css/twitter.css?cache=4" />
<!--[if lt IE 8]>
<link rel="stylesheet" type="text/css" href="/elements/css/ie7.css?cache=4" media="screen" />
<![endif]-->
<!--[if lt IE 7]>
<link rel="stylesheet" type="text/css" href="/elements/css/ie6.css?cache=4" media="screen" />
<![endif]-->
<script type="text/javascript" src="/elements/js/jquery-1.7.1.js"></script>
<script type="text/javascript" src="/elements/js/jquery.easing.js"></script>
<script type="text/javascript" src="/elements/js/jquery.hoverIntent.minified.js"></script>
<script type="text/javascript">
var j = jQuery.noConflict();
</script>
<script type="text/javascript" src="/elements/js/swfobject.js"></script>
<script type="text/javascript" src="/elements/js/jquery.js"></script>
<script type="text/javascript" src="/elements/js/pages/base.js?cache=4"></script>
<script type="text/javascript">var switchTo5x=true;</script>
<script type="text/javascript" src="http://w.sharethis.com/button/buttons.js"></script>
<script type="text/javascript">stLight.options({publisher:'e38fc981-ddf5-422b-8048-66194695e9ab'});</script>
<script type="text/javascript">
var slides = [
{
'title': 'The New Health Alliance',
'text': '\x3Cp\x3ETo successfully increase shareholder value, mitigate risk, and improve clinical execution, biopharmaceutical companies must explore alliances that meet the needs of the New Health and produce medicines that speak to the needs of the entire constellation of stakeholders. This paper explores the reasons for a new partnership model, and offers suggestions for how to construct an alliance appropriate for the realities of the New Health.\x3C/p\x3E',
'twitter': 'https://twitter.com/intent/tweet?url\x3Dhttp://www.quintiles.com/information\x2Dlibrary/white\x2Dpapers/new\x2Dhealth\x2Dalliance/',
'linkedin': 'http://www.linkedin.com/shareArticle?mini\x3Dtrue\x26url\x3Dhttp://www.quintiles.com/information\x2Dlibrary/white\x2Dpapers/new\x2Dhealth\x2Dalliance/',
'email': 'mailto:?body\x3Dhttp://www.quintiles.com/information\x2Dlibrary/white\x2Dpapers/new\x2Dhealth\x2Dalliance/',
'learnMoreText': 'Learn more',
'learnMoreURL': '/information-library/white-papers/new-health-alliance/',
'image': '/elements/media/homepage-slides/new-health-alliance.jpg'
},
{
'title': 'An Integrated Approach to Biosimilar Development \x26 Commercialization',
'text': '\x3Cp\x3EQuintiles firmly believes that biosimilar products pose a unique and important opportunity to improve the access to and affordability of new medicines around the globe. Our recent white paper stresses that successful biosimilar companies will be those who collapse their clinical, commercial, and regulatory thinking into a streamlined cohesive function as they proceed with developing biosimilars.\x3C/p\x3E',
'twitter': 'https://twitter.com/intent/tweet?url\x3Dhttp://www.quintiles.com/information\x2Dlibrary/white\x2Dpapers/integrated\x2Dapproach\x2Dbiosimilar\x2Ddevelopment\x2Dcommercialization/',
'linkedin': 'http://www.linkedin.com/shareArticle?mini\x3Dtrue\x26url\x3Dhttp://www.quintiles.com/information\x2Dlibrary/white\x2Dpapers/integrated\x2Dapproach\x2Dbiosimilar\x2Ddevelopment\x2Dcommercialization/',
'email': 'mailto:?body\x3Dhttp://www.quintiles.com/information\x2Dlibrary/white\x2Dpapers/integrated\x2Dapproach\x2Dbiosimilar\x2Ddevelopment\x2Dcommercialization/',
'learnMoreText': 'Read white paper',
'learnMoreURL': '/information-library/white-papers/integrated-approach-biosimilar-development-commercialization/',
'image': '/elements/media/homepage-slides/integrated-approach-biosimilar-development-commercialization.jpeg'
},
{
'title': 'Proving value in oncology',
'text': '\x3Cp\x3EThere’s a new twist in the steep and costly road to market for oncology therapies. Stakeholders are looking for evidence of value beyond clinical efficacy. To add to the complexity: payers, providers, patients all define value differently. Discover all the facets of the value challenge in oncology drug development.\x3C/p\x3E',
'twitter': 'https://twitter.com/intent/tweet?url\x3Dhttp://www.quintiles.com/newhealth/demonstrate\x2Dvalue\x2Doncology/',
'linkedin': 'http://www.linkedin.com/shareArticle?mini\x3Dtrue\x26url\x3Dhttp://www.quintiles.com/newhealth/demonstrate\x2Dvalue\x2Doncology/',
'email': 'mailto:?body\x3Dhttp://www.quintiles.com/newhealth/demonstrate\x2Dvalue\x2Doncology/',
'learnMoreText': 'Learn more',
'learnMoreURL': '/newhealth/demonstrate-value-oncology/',
'image': '/elements/media/homepage-slides/proving-value-oncology.jpg'
},
{
'title': 'Data insights drive better decisions',
'text': '\x3Cp\x3EWhat if you could see your drug development from every angle — with immediate transparency across every data source? Quintiles Infosario™ unlocks trial intelligence to deliver insights you can act on immediately. This comprehensive suite of data\x2Ddriven services changes everything.\x3C/p\x3E',
'twitter': 'https://twitter.com/intent/tweet?url\x3Dhttp://www.quintiles.com/clinical\x2Dservices/quintiles\x2Dinfosario/',
'linkedin': 'http://www.linkedin.com/shareArticle?mini\x3Dtrue\x26url\x3Dhttp://www.quintiles.com/clinical\x2Dservices/quintiles\x2Dinfosario/',
'email': 'mailto:?body\x3Dhttp://www.quintiles.com/clinical\x2Dservices/quintiles\x2Dinfosario/',
'learnMoreText': 'Watch video',
'learnMoreURL': '/clinical-services/quintiles-infosario/',
'image': '/elements/media/homepage-slides/data-insights-drive-better-decisions.jpg'
},
{
'title': 'Navigate risk. Seize opportunity.',
'text': '\x3Cp\x3ETo succeed in the \x3Cem\x3ENew Health\x3C/em\x3E, you have to stay at least three steps ahead. After 30 years in the industry, we’re still energized by thinking forward, by discovering new perspectives on biopharma’s biggest challenges. See what our experts are saying on topics from strategic alliances to biosimilars.\x3C/p\x3E',
'twitter': 'https://twitter.com/intent/tweet?url\x3Dhttp://www.quintiles.com/perspectives/',
'linkedin': 'http://www.linkedin.com/shareArticle?mini\x3Dtrue\x26url\x3Dhttp://www.quintiles.com/perspectives/',
'email': 'mailto:?body\x3Dhttp://www.quintiles.com/perspectives/',
'learnMoreText': 'Explore our thinking',
'learnMoreURL': '/perspectives/',
'image': '/elements/media/homepage-slides/navigate-risk-seize-opportunity.jpg'
},
{
'title': 'Optimize your trial before it starts',
'text': '\x3Cp\x3EBe prepared for obstacles and landmines before you commit the capital, time and resources to your next drug trial. Model\x2DBased Drug Development can simulate and predict the potential scenarios for your compound to give your molecule the best chance of success.\x3C/p\x3E',
'twitter': 'https://twitter.com/intent/tweet?url\x3Dhttp://www.quintiles.com/clinical\x2Dservices/model\x2Dbased\x2Ddrug\x2Ddevelopment/',
'linkedin': 'http://www.linkedin.com/shareArticle?mini\x3Dtrue\x26url\x3Dhttp://www.quintiles.com/clinical\x2Dservices/model\x2Dbased\x2Ddrug\x2Ddevelopment/',
'email': 'mailto:?body\x3Dhttp://www.quintiles.com/clinical\x2Dservices/model\x2Dbased\x2Ddrug\x2Ddevelopment/',
'learnMoreText': 'Watch video',
'learnMoreURL': '/clinical-services/model-based-drug-development/',
'image': '/elements/media/homepage-slides/optimize-your-trial-it-starts.jpg'
}
];
var tweets = [
{
'tweetHTML': 'Customers only! Vote for Quintiles as Best CRO of 2011. Winners announced @ World Vaccine Congress April 10\x2D13 in D.C. \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/MaHyisK8\x22\x3Ehttp://t.co/MaHyisK8\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/180341833442930688',
'timeSince': '12 hours ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=180341833442930688',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=180341833442930688',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=180341833442930688'
},
{
'tweetHTML': 'Asia Chief Medical Officer looks toward Asia as a unique opportunity for “radical transformation\x22 of #biopharma \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/32xggJiY\x22\x3Ehttp://t.co/32xggJiY\x3C/a\x3E #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/180186703242346496',
'timeSince': '23 hours ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=180186703242346496',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=180186703242346496',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=180186703242346496'
},
{
'tweetHTML': 'The #biopharma industry needs a radical transformation, and Asia offers a unique opportunity for remodeling the system. \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/hWEB2fo1\x22\x3Ehttp://t.co/hWEB2fo1\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/180097321051226112',
'timeSince': '1 day ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=180097321051226112',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=180097321051226112',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=180097321051226112'
},
{
'tweetHTML': 'Great conversations sparked at #Calbio2012. Listen to Adrian McKemey\x27s podcast on clinical trials of the future \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/WcZI32j6\x22\x3Ehttp://t.co/WcZI32j6\x3C/a\x3E #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/179644292502007808',
'timeSince': '2 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=179644292502007808',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=179644292502007808',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=179644292502007808'
},
{
'tweetHTML': 'Thanks for the RTs! @ChipButterworth @PMPConnect @MaxResourcing @RXKapil @McKemey57 @ShaneKJamal @ScottPage100',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/179596669552300033',
'timeSince': '2 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=179596669552300033',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=179596669552300033',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=179596669552300033'
},
{
'tweetHTML': 'Research from @TheEIU: 52% of value leaders said they have increased coordination between commercial and R\x26amp\x3BD \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/0tNQvIrz\x22\x3Ehttp://t.co/0tNQvIrz\x3C/a\x3E #biopharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/179586566426066946',
'timeSince': '2 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=179586566426066946',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=179586566426066946',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=179586566426066946'
},
{
'tweetHTML': 'Learn about our advanced bioanalytical capabilities, strengthened by our colleagues at Advion Bioanalytical Labs. Booth #216 #ASCPT2012',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/179567531760168960',
'timeSince': '2 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=179567531760168960',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=179567531760168960',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=179567531760168960'
},
{
'tweetHTML': 'Talk to Dr. Seth Berry about how to boost your compound\x27s probability of success. Visit us at booth #216 \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/ZlouBAs2\x22\x3Ehttp://t.co/ZlouBAs2\x3C/a\x3E #ASCPT2012',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/179290534748233729',
'timeSince': '3 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=179290534748233729',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=179290534748233729',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=179290534748233729'
},
{
'tweetHTML': '#Calbio2012 Industry panel on modernizing clinical trials sees \x27perfect storm\x27 of innovation rising to meet critical needs \x2D A.M. #biopharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/179178790247866368',
'timeSince': '3 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=179178790247866368',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=179178790247866368',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=179178790247866368'
},
{
'tweetHTML': 'Adrian McKemey discusses clinical trials of the future in podcast from #CALBIO 2012 \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/W36yKIuP\x22\x3Ehttp://t.co/W36yKIuP\x3C/a\x3E #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/178203837784530944',
'timeSince': '6 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=178203837784530944',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=178203837784530944',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=178203837784530944'
},
{
'tweetHTML': 'Attending @TheAMGA be sure to stop by the Outcome booth to learn more about the PQRI Registry \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/wzrAPFZc\x22\x3Ehttp://t.co/wzrAPFZc\x3C/a\x3E #AMGA',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/178133076583526400',
'timeSince': '6 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=178133076583526400',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=178133076583526400',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=178133076583526400'
},
{
'tweetHTML': 'JOB OPPORTUNITY \x2D POLAND. Senior CRA Opportunity. Office or home\x2Dbased roll\x3B 60% travel. Please visit \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/OB2jfq0m\x22\x3Ehttp://t.co/OB2jfq0m\x3C/a\x3E for details',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/178038703342624768',
'timeSince': '6 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=178038703342624768',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=178038703342624768',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=178038703342624768'
},
{
'tweetHTML': '\x27FDA needs to advance adaptive trials and conditional approval\x22 V. Eschenbach \x2D A.M. #Calbio2012',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/177819586736037889',
'timeSince': '7 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=177819586736037889',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=177819586736037889',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=177819586736037889'
},
{
'tweetHTML': '\x22New care delivery decisions will involve Dr., patient and Watson\x22 I agree we are on verge of leveraging massive information \x2DAM #Calbio2012',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/177818208689065984',
'timeSince': '7 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=177818208689065984',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=177818208689065984',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=177818208689065984'
},
{
'tweetHTML': 'Adrian McKemey, VP of consulting and practical lead of product development group at Quintiles, live tweeting from #Calbio2012 @BayBio',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/177817725727539200',
'timeSince': '7 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=177817725727539200',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=177817725727539200',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=177817725727539200'
},
{
'tweetHTML': 'Latin America Clinical Trials Conf. Learn about challenges \x26 opportunities facing clinical research in the region \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/YznGqFU8\x22\x3Ehttp://t.co/YznGqFU8\x3C/a\x3E #CRO',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/177744264665636864',
'timeSince': '7 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=177744264665636864',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=177744264665636864',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=177744264665636864'
},
{
'tweetHTML': 'Attending BioPharma Asia? Visit us at booth #D1 to learn about #Infosario and enter to win an iPad \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/njREOlOz\x22\x3Ehttp://t.co/njREOlOz\x3C/a\x3E @Biopharmaasia',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/177672545783398400',
'timeSince': '7 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=177672545783398400',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=177672545783398400',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=177672545783398400'
},
{
'tweetHTML': 'Evolving the Oncology Paradigm\x3B Identifying critical value endpoints to design more efficient clinical trials [VIDEO] \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/eDmQ3WpT\x22\x3Ehttp://t.co/eDmQ3WpT\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/177462604334243841',
'timeSince': '8 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=177462604334243841',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=177462604334243841',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=177462604334243841'
},
{
'tweetHTML': 'Going to ASCPT? Visit us at booth #216 and register for a chance to win an iPad! \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/bEjknZMW\x22\x3Ehttp://t.co/bEjknZMW\x3C/a\x3E #ASCPT2012 #CRO',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/177418870754258945',
'timeSince': '8 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=177418870754258945',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=177418870754258945',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=177418870754258945'
},
{
'tweetHTML': 'FREE webinar on 3/21: The Right Research Approach for the Right Question: Quality? Safety? Efficacy? Effectiveness? \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/5nIO8xoA\x22\x3Ehttp://t.co/5nIO8xoA\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/177117639167066113',
'timeSince': '9 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=177117639167066113',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=177117639167066113',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=177117639167066113'
},
{
'tweetHTML': 'Be sure visit Outcome, at booth #904 to learn about real\x2Dworld and late phase research services @Quintiles @PartnershipCROs #PCTUS',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/177109248281554944',
'timeSince': '9 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=177109248281554944',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=177109248281554944',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=177109248281554944'
},
{
'tweetHTML': 'Boost Productivity During Early Clinical Development \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/wRAkrXZs\x22\x3Ehttp://t.co/wRAkrXZs\x3C/a\x3E Visit us at booth 216 to learn more #ASCPT2012 #biopharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/177071533259362304',
'timeSince': '9 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=177071533259362304',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=177071533259362304',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=177071533259362304'
},
{
'tweetHTML': 'Never say never: Inside Quintiles at age 30, a story of remarkable growth \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/enOg7i7S\x22\x3Ehttp://t.co/enOg7i7S\x3C/a\x3E via @WRALTechWire #CRO #pharma #biopharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/176451854719389697',
'timeSince': '11 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=176451854719389697',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=176451854719389697',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=176451854719389697'
},
{
'tweetHTML': '@JorgeAriasLopez What a delicious way to celebrate the @Quintiles 30th anniversary! Enjoy!',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/175578801533763584',
'timeSince': '13 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=175578801533763584',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=175578801533763584',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=175578801533763584'
},
{
'tweetHTML': 'Thanks for the #FF! @LifeScienceMuse @philipshealth @RAPSorg @MedDevicesDaily @ADiamantidis @LinguaGreca @jessicarlondon @kvashee',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/175571282312699904',
'timeSince': '13 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=175571282312699904',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=175571282312699904',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=175571282312699904'
},
{
'tweetHTML': 'Quintiles discusses social media as a new recruitment strategy for clinical trials.\x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://bit.ly/x5U4zx\x22\x3Ehttp://bit.ly/x5U4zx\x3C/a\x3E via @ihealthbeat @socpharm #hcsm',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/175563952447692800',
'timeSince': '13 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=175563952447692800',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=175563952447692800',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=175563952447692800'
},
{
'tweetHTML': 'The top 18% of biopharmas produce almost twice as many new products as the rest. \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/8z75OZF3\x22\x3Ehttp://t.co/8z75OZF3\x3C/a\x3E [VIDEO] #biopharma #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/175205955817050112',
'timeSince': '14 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=175205955817050112',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=175205955817050112',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=175205955817050112'
},
{
'tweetHTML': '@PainCHAS Thanks!',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174976018891812864',
'timeSince': '15 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174976018891812864',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174976018891812864',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174976018891812864'
},
{
'tweetHTML': 'Companies have different views of stakeholders\x27 influence in the life sciences industry. \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/I2B4mYdH\x22\x3Ehttp://t.co/I2B4mYdH\x3C/a\x3E #oncology #pharma #biopharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174961955415658496',
'timeSince': '15 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174961955415658496',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174961955415658496',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174961955415658496'
},
{
'tweetHTML': 'Thanks for the birthday wishes @invivodata @datatrakinc !',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174942912755400704',
'timeSince': '15 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174942912755400704',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174942912755400704',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174942912755400704'
},
{
'tweetHTML': 'New study: The world is ready for mobile healthcare \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/MzVWmJ7h\x22\x3Ehttp://t.co/MzVWmJ7h\x3C/a\x3E via @Reuters #hcsm #socpharm #epatient',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174942178114670592',
'timeSince': '15 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174942178114670592',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174942178114670592',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174942178114670592'
},
{
'tweetHTML': 'Today is Rare Disease Day Share your story/Make a difference visit the official @RareDiseases page \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/INGBjKUz\x22\x3Ehttp://t.co/INGBjKUz\x3C/a\x3E #NORD #raredisease',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174925815971188736',
'timeSince': '15 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174925815971188736',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174925815971188736',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174925815971188736'
},
{
'tweetHTML': '56% of drug makers say their greatest obstacle is multiple stakeholders varying definitions of value \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/CvV0pJvS\x22\x3Ehttp://t.co/CvV0pJvS\x3C/a\x3E [VIDEO] #biopharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174893876438515712',
'timeSince': '15 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174893876438515712',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174893876438515712',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174893876438515712'
},
{
'tweetHTML': '@pastephens Thanks, Phil!! And thanks for your help! :)',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174644681513246720',
'timeSince': '16 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174644681513246720',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174644681513246720',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174644681513246720'
},
{
'tweetHTML': 'Thanks for sharing our anniversary news! @SteveBNC @Researchnurses @kbarnesrtp @lifesciencemuse @Computype @ScottPage100 @LeeKennedy',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174643551580332033',
'timeSince': '16 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174643551580332033',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174643551580332033',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174643551580332033'
},
{
'tweetHTML': '\x22From Trailer to 25K Employees\x22 @TriangleBIZJrnl covers our 30\x2Dyr anniversary. \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/kOJewx9f\x22\x3Ehttp://t.co/kOJewx9f\x3C/a\x3E #pharma #RTP #CRO',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174561797934821378',
'timeSince': '16 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174561797934821378',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174561797934821378',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174561797934821378'
},
{
'tweetHTML': 'Last Week to Receive Early Registration Discount for Post\x2DApproval Summit 5/1\x2D2 @HarvardMed #CER #Outcomes #patients \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/SvVoxMbW\x22\x3Ehttp://t.co/SvVoxMbW\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174561544233959424',
'timeSince': '16 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174561544233959424',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174561544233959424',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174561544233959424'
},
{
'tweetHTML': '@RebarInter Thank you \x2D it is quite a milestone!',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174558628475453440',
'timeSince': '16 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174558628475453440',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174558628475453440',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174558628475453440'
},
{
'tweetHTML': '\x22From Trailer to 25K Employees\x22 @TriangleBIZJrnl covers our 30\x2Dyr anniversary. #pharma #RTP #CRO',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174557322033635328',
'timeSince': '16 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174557322033635328',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174557322033635328',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174557322033635328'
},
{
'tweetHTML': 'Thanks for the RTs @SudhaKanago @npemptage @ScottPage100 The Value Challenge \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/b5ih2Dlu\x22\x3Ehttp://t.co/b5ih2Dlu\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174515592647294976',
'timeSince': '16 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174515592647294976',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174515592647294976',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174515592647294976'
},
{
'tweetHTML': 'Quintiles is celebrating 30 yrs as a #biopharma service provider! Learn about our incredible journey here \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/fA4Ebyb7\x22\x3Ehttp://t.co/fA4Ebyb7\x3C/a\x3E #CRO #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174505307840593920',
'timeSince': '16 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174505307840593920',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174505307840593920',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174505307840593920'
},
{
'tweetHTML': 'Demand for proof of value is rewriting how the #biopharma industry approaches drug development. \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/b5ih2Dlu\x22\x3Ehttp://t.co/b5ih2Dlu\x3C/a\x3E @EIU #pharma #oncology',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174498523214123008',
'timeSince': '16 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174498523214123008',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174498523214123008',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174498523214123008'
},
{
'tweetHTML': 'Quintiles proudly announces the extension of our sponsorship of the Marathon in Wrightsville Beach through 2015. \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/yvz2tF3u\x22\x3Ehttp://t.co/yvz2tF3u\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174200833196568578',
'timeSince': '17 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174200833196568578',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174200833196568578',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174200833196568578'
},
{
'tweetHTML': 'Accelerating Patient Recruitment \x2D Explore the role of education in optimizing #patient ID and recruitment \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/9kOHrL2v\x22\x3Ehttp://t.co/9kOHrL2v\x3C/a\x3E #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174181892248190976',
'timeSince': '17 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174181892248190976',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174181892248190976',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174181892248190976'
},
{
'tweetHTML': 'Assessing Strengths and Weaknesses of Study Designs and Analytic Methods for Comparative Effectiveness Research\x0A\x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/hC8OycVD\x22\x3Ehttp://t.co/hC8OycVD\x3C/a\x3E #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174144123568263170',
'timeSince': '17 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174144123568263170',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174144123568263170',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174144123568263170'
},
{
'tweetHTML': 'Go beyond study management to accelerate your drug development processes \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/wQBXn9bh\x22\x3Ehttp://t.co/wQBXn9bh\x3C/a\x3E #biopharma #pharma #CRO #IT',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174120778713923584',
'timeSince': '17 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174120778713923584',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174120778713923584',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174120778713923584'
},
{
'tweetHTML': 'Thanks for the RTs. Have a great week! @johnreites @excointouch @ChipButterworth @duffeleanor @CharlieReece',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174117754964680704',
'timeSince': '17 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174117754964680704',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174117754964680704',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174117754964680704'
},
{
'tweetHTML': '@Berci @jvalaball Happy to help!',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174117048052482048',
'timeSince': '17 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174117048052482048',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174117048052482048',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174117048052482048'
},
{
'tweetHTML': 'You too! @andrewspong @CompareSoftware @PureMountains @DanBax76 @SpitzStrategy @H2Ohu @carlenlea @Clarejo @bowelcancer @whydotpharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/174116682397270016',
'timeSince': '17 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=174116682397270016',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=174116682397270016',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=174116682397270016'
},
{
'tweetHTML': 'Just Click Here @DaveComan discusses social media and #patient recruitment \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/Q51hkKj3\x22\x3Ehttp://t.co/Q51hkKj3\x3C/a\x3E @medadnews #clinicaltrials #socpharm',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/173167413389570048',
'timeSince': '20 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=173167413389570048',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=173167413389570048',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=173167413389570048'
},
{
'tweetHTML': 'Thanks for sharing today\x27s news @Fiercebiotech and @contractpharma \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/7sxPrvvt\x22\x3Ehttp://t.co/7sxPrvvt\x3C/a\x3E #pharma #biotech #CRO',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/173120813669683201',
'timeSince': '20 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=173120813669683201',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=173120813669683201',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=173120813669683201'
},
{
'tweetHTML': 'Thanks for today\x27s RTs! @mistersugar @Pharma4Life @pharmaphorum @ScottPage100 @Stan_cherry @CharlieReece #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/173120001413349376',
'timeSince': '20 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=173120001413349376',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=173120001413349376',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=173120001413349376'
},
{
'tweetHTML': 'Healthcare social media communities on Twitter \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/Ztq0lB4q\x22\x3Ehttp://t.co/Ztq0lB4q\x3C/a\x3E via @andrewspong #hcsm #hcsmeu',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/173093862569545728',
'timeSince': '20 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=173093862569545728',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=173093862569545728',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=173093862569545728'
},
{
'tweetHTML': '@Berci here\x27s two: #epatient #mobilehealth',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/173092803772039169',
'timeSince': '20 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=173092803772039169',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=173092803772039169',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=173092803772039169'
},
{
'tweetHTML': 'Quintiles and Russian Venture Company Biofund to Expand Clinical Development Capabilities in Russia \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/7sxPrvvt\x22\x3Ehttp://t.co/7sxPrvvt\x3C/a\x3E #CRO #biopharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/173081069858467840',
'timeSince': '20 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=173081069858467840',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=173081069858467840',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=173081069858467840'
},
{
'tweetHTML': 'Explore the role of education in optimizing patient identification and recruitment \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/E4aY1s86\x22\x3Ehttp://t.co/E4aY1s86\x3C/a\x3E #biopharma #patients',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/173046653580873728',
'timeSince': '20 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=173046653580873728',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=173046653580873728',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=173046653580873728'
},
{
'tweetHTML': 'Healthcare industry executives say demonstrating value is most difficult in the field of #oncology. \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/CvV0pJvS\x22\x3Ehttp://t.co/CvV0pJvS\x3C/a\x3E [video] #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/172787460093378561',
'timeSince': '21 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=172787460093378561',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=172787460093378561',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=172787460093378561'
},
{
'tweetHTML': 'Great content coming out of the 2nd Annual Patient #Adherence Summit.Good mix of academic, physicians, and industry attendees. #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/172775846375989248',
'timeSince': '21 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=172775846375989248',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=172775846375989248',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=172775846375989248'
},
{
'tweetHTML': 'The 2nd Annual Patient Adherence Summit starts today. Should be a great meeting. R.T. \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/mQHx83Wy\x22\x3Ehttp://t.co/mQHx83Wy\x3C/a\x3E #patient #adherence #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/172722955212701696',
'timeSince': '21 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=172722955212701696',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=172722955212701696',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=172722955212701696'
},
{
'tweetHTML': '#HIMSS12 Interoperability Showcase \x2D Outcome and @AllScripts demonstrate example of #cancer case reporting to the #CDC \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/YBayNZQv\x22\x3Ehttp://t.co/YBayNZQv\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/172352518901346304',
'timeSince': '22 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=172352518901346304',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=172352518901346304',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=172352518901346304'
},
{
'tweetHTML': 'What can be done to reinvigorate innovation efforts within the life sciences industry? \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/Euj1ZSL5\x22\x3Ehttp://t.co/Euj1ZSL5\x3C/a\x3E @TheEIU #biopharma #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/172347177522307073',
'timeSince': '22 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=172347177522307073',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=172347177522307073',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=172347177522307073'
},
{
'tweetHTML': 'What is value? 63% of respondents from the #Biopharma industry defined value as “improved efficacy over existing drugs” \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/I2B4mYdH\x22\x3Ehttp://t.co/I2B4mYdH\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/172061191047364608',
'timeSince': '23 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=172061191047364608',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=172061191047364608',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=172061191047364608'
},
{
'tweetHTML': 'Can\x27t attend #HIMSS12? You can access speaker presentations here \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/XIoSXpS6\x22\x3Ehttp://t.co/XIoSXpS6\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/172058526640898048',
'timeSince': '23 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=172058526640898048',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=172058526640898048',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=172058526640898048'
},
{
'tweetHTML': 'Pharma looks to mobile strategies to effectively reach prescribers \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/N4t1G2qk\x22\x3Ehttp://t.co/N4t1G2qk\x3C/a\x3E via @mHimss #HIMSS12 #socpharm',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/172039808238104576',
'timeSince': '23 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=172039808238104576',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=172039808238104576',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=172039808238104576'
},
{
'tweetHTML': 'Ready to transform your drug development with true data intelligence? [Video] \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/wQBXn9bh\x22\x3Ehttp://t.co/wQBXn9bh\x3C/a\x3E #Infosario #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/171948877774209025',
'timeSince': '23 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=171948877774209025',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=171948877774209025',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=171948877774209025'
},
{
'tweetHTML': 'Good Luck! MT @PinkPacers 694 currently registered for the Quintiles GOTR Spring 5k! Help them get to 700 by tomorrow. \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/rUUDWCpY\x22\x3Ehttp://t.co/rUUDWCpY\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/171704228610441216',
'timeSince': '24 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=171704228610441216',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=171704228610441216',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=171704228610441216'
},
{
'tweetHTML': 'Model\x2DBased Drug Development \x2D\x0ASmarter decisions, better returns in the New Health \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/8z75OZF3\x22\x3Ehttp://t.co/8z75OZF3\x3C/a\x3E #pharma #biotech #CRO',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/171655850149158912',
'timeSince': '24 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=171655850149158912',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=171655850149158912',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=171655850149158912'
},
{
'tweetHTML': 'Explore the role of education in optimizing patient outcomes \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/Nh3OztZG\x22\x3Ehttp://t.co/Nh3OztZG\x3C/a\x3E @Advanstar_CBI #pharma #outcomes #patients',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/170615839215718400',
'timeSince': '27 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=170615839215718400',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=170615839215718400',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=170615839215718400'
},
{
'tweetHTML': 'How do we ensure speed\x2Dto\x2Dmarket while maintaining a high quality of clinical evidence? \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/wgjnebQG\x22\x3Ehttp://t.co/wgjnebQG\x3C/a\x3E #biosimilars #biopharma #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/170566512145473536',
'timeSince': '27 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=170566512145473536',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=170566512145473536',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=170566512145473536'
},
{
'tweetHTML': 'A game\x2Dchanger\x3B 3 Reasons why #pharma and #biotech need the iPad. \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/fSoBCmDD\x22\x3Ehttp://t.co/fSoBCmDD\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/170544266450452480',
'timeSince': '27 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=170544266450452480',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=170544266450452480',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=170544266450452480'
},
{
'tweetHTML': 'Congratulations to Q employees Steven Killer and Louise Armitage, finalists for the 2011 @Pharmatimes Clinical Researcher of of the Year.',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/170325263815671808',
'timeSince': '28 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=170325263815671808',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=170325263815671808',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=170325263815671808'
},
{
'tweetHTML': 'It used to be enough to prove an oncology drug is safe and effective to gain market acceptance. Not anymore \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/CvV0pJvS\x22\x3Ehttp://t.co/CvV0pJvS\x3C/a\x3E #biopharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/170228787986972672',
'timeSince': '28 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=170228787986972672',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=170228787986972672',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=170228787986972672'
},
{
'tweetHTML': 'The New Value Challenge: How to Accelerate Success in Oncology \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/P6HBjzED\x22\x3Ehttp://t.co/P6HBjzED\x3C/a\x3E #biopharma #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/169811298832498688',
'timeSince': '29 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=169811298832498688',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=169811298832498688',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=169811298832498688'
},
{
'tweetHTML': 'Additional thanks to @Sherlycaponira @TextingAds @mypharma @kuwaityoon and @cystron for sharing our story \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/nVXTdadr\x22\x3Ehttp://t.co/nVXTdadr\x3C/a\x3E #biopharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/169779685314670593',
'timeSince': '29 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=169779685314670593',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=169779685314670593',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=169779685314670593'
},
{
'tweetHTML': 'Thanks to @OutsourcPharma @WRALTechWire @FrankVinluan @PharmOutsource for sharing yesterday\x27s MENA news. #biopharma #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/169778359113490432',
'timeSince': '29 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=169778359113490432',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=169778359113490432',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=169778359113490432'
},
{
'tweetHTML': '@njcurescancer @Duke_Childrens thanks for spreading the word!',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/169513901514424320',
'timeSince': '30 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=169513901514424320',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=169513901514424320',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=169513901514424320'
},
{
'tweetHTML': 'There\x27s still time to make a donation for the @Duke_Childrens Hospital Radiothon! Donate and listen live! \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/5wKjcirH\x22\x3Ehttp://t.co/5wKjcirH\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/169513097655103488',
'timeSince': '30 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=169513097655103488',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=169513097655103488',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=169513097655103488'
},
{
'tweetHTML': 'Quintiles Expands Commercial Services in MENA and signs strategic partnership with Dayarn Pharma \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/nVXTdadr\x22\x3Ehttp://t.co/nVXTdadr\x3C/a\x3E #biopharma #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/169449759545896960',
'timeSince': '30 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=169449759545896960',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=169449759545896960',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=169449759545896960'
},
{
'tweetHTML': '@Duke_Childrens WOW!! We\x27re thrilled to be involved with such an incredible cause. Keep those donations coming! \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/5wKjcirH\x22\x3Ehttp://t.co/5wKjcirH\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/169442269928243200',
'timeSince': '30 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=169442269928243200',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=169442269928243200',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=169442269928243200'
},
{
'tweetHTML': '@JohnCFierce @RandDDirections @FDALawyers Thanks for sharing our news on drug dev and consulting services targeting Asia. #biopharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/169173702133547008',
'timeSince': '31 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=169173702133547008',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=169173702133547008',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=169173702133547008'
},
{
'tweetHTML': 'For the 5th year we\x27re sponsoring @Duke_Childrens Miracle Network Radiothon! The event kick\x27s off tomorrow! \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/5wKjcirH\x22\x3Ehttp://t.co/5wKjcirH\x3C/a\x3E',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/169171928370786305',
'timeSince': '31 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=169171928370786305',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=169171928370786305',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=169171928370786305'
},
{
'tweetHTML': '@TheRealDanSfera All is going great and even more great stuff on the horizon. Make sure you\x27re following! :)',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/168329460746170368',
'timeSince': '33 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=168329460746170368',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=168329460746170368',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=168329460746170368'
},
{
'tweetHTML': 'Thanks for sharing! MT @RebarInter Curious about @Quintiles\x27 new Digital Patient Unit? \x3Ca target\x3D\x22_blank\x22 href\x3D\x22http://t.co/uICWo0xW\x22\x3Ehttp://t.co/uICWo0xW\x3C/a\x3E @clin_trials #epatient #pharma',
'tweetLink': 'https://twitter.com/#!/Quintiles/status/168028927133106176',
'timeSince': '34 days ago',
'replyLink': 'https://twitter.com/intent/tweet?in_reply_to=168028927133106176',
'retweetLink': 'https://twitter.com/intent/retweet?tweet_id=168028927133106176',
'favoriteLink': 'https://twitter.com/intent/favorite?tweet_id=168028927133106176'
},
{
'tweetHTML': 'Great discussions sparked during yesterday\x27s #pharmasummit. Download FREE EIU paper on value for additional insights \x3Ca target\x3D\x22